May 02, 2024 / 12:30PM GMT
Operator
Greetings and welcome to the Aurinia Pharmaceuticals First Quarter 2024 earnings call. At this time, all participants are in listen only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It's now my pleasure to turn the conference over to Andrea christopher, Head of Corporate Communications and Investor Relations for Aurinia Pharmaceuticals.
Andrea Christopher - Aurinia Pharmaceuticals Inc - Head of Corporate Communications and Investor Relations
Please go ahead.
Thank you, operator, and thank you to everyone for joining today's call and webcast. Joining me on the call this morning are Peter Greenleaf, Aurinia's Chief Executive Officer, Joe Miller, our Chief Financial Officer, and Dr. Greg Keenan, our Chief Medical Officer. Today, we will review and discuss earning of 2024 first quarter financial and operational results. As communicated in the company's press release issued this morning,
Q1 2024 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot